BRPI0210317C1 - complexo de vacina terapêutica destinado à prevenção ou ao tratamento de leishmanioses e infecções mediadas por microorganismos patogênicos intracelulares nos mamíferos - Google Patents
complexo de vacina terapêutica destinado à prevenção ou ao tratamento de leishmanioses e infecções mediadas por microorganismos patogênicos intracelulares nos mamíferosInfo
- Publication number
- BRPI0210317C1 BRPI0210317C1 BRPI0210317A BR0210317A BRPI0210317C1 BR PI0210317 C1 BRPI0210317 C1 BR PI0210317C1 BR PI0210317 A BRPI0210317 A BR PI0210317A BR 0210317 A BR0210317 A BR 0210317A BR PI0210317 C1 BRPI0210317 C1 BR PI0210317C1
- Authority
- BR
- Brazil
- Prior art keywords
- leishmaniasis
- mammals
- prevention
- treatment
- pathogenic microorganisms
- Prior art date
Links
- 208000004554 Leishmaniasis Diseases 0.000 title abstract 3
- 241000124008 Mammalia Species 0.000 title abstract 3
- 208000015181 infectious disease Diseases 0.000 title abstract 3
- 230000003834 intracellular effect Effects 0.000 title abstract 3
- 230000001404 mediated effect Effects 0.000 title abstract 3
- 244000000010 microbial pathogen Species 0.000 title abstract 3
- 230000002265 prevention Effects 0.000 title abstract 3
- 229940021747 therapeutic vaccine Drugs 0.000 title abstract 3
- 241000282465 Canis Species 0.000 abstract 1
- 241000282324 Felis Species 0.000 abstract 1
- 241001137872 Leishmania sp. Species 0.000 abstract 1
- 230000029142 excretion Effects 0.000 abstract 1
- 230000028327 secretion Effects 0.000 abstract 1
- 239000012679 serum free medium Substances 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/002—Protozoa antigens
- A61K39/008—Leishmania antigens
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P33/00—Antiparasitic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P33/00—Antiparasitic agents
- A61P33/02—Antiprotozoals, e.g. for leishmaniasis, trichomoniasis, toxoplasmosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
- A61K2039/55511—Organic adjuvants
- A61K2039/55566—Emulsions, e.g. Freund's adjuvant, MF59
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/57—Medicinal preparations containing antigens or antibodies characterised by the type of response, e.g. Th1, Th2
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
- Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
- Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Tropical Medicine & Parasitology (AREA)
- Veterinary Medicine (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Mycology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Immunology (AREA)
- Microbiology (AREA)
- Organic Chemistry (AREA)
- Epidemiology (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
- Fodder In General (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
Abstract
complexo de vacina terapêutica destinado à prevenção ou ao tratamento de leishmanioses e infecções mediadas por microorganismos patogênicos intracelulares nos mamíferos complexo de vacina terapêutica destinado à prevenção ou ao tratamento de leishmanioses e infecções mediadas por microorganismos patogênicos intracelulares nos mamíferos e em particular no homem, nos caninos, nos felinos e nos eqüídeos, caracterizado pelo fato de que ele é composto por moléculas de excreção secreção provenientes de promastigotos de leishmania sp. produzidos em um meio sem germes e sem soro definido.
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| FR0107606A FR2825633B1 (fr) | 2001-06-11 | 2001-06-11 | Complexe vaccinal therapeutique destine a la prevention et au traitement des leishmanioses et des infections a microorganismes pathogenes intracellulaires chez le mammifere |
| PCT/FR2002/001823 WO2002100430A1 (fr) | 2001-06-11 | 2002-05-30 | Complexe vaccinal destine a la prevention et au traitement des leishmanioses |
Publications (4)
| Publication Number | Publication Date |
|---|---|
| BR0210317A BR0210317A (pt) | 2004-08-10 |
| BRPI0210317B1 BRPI0210317B1 (pt) | 2018-09-11 |
| BRPI0210317B8 BRPI0210317B8 (pt) | 2018-10-09 |
| BRPI0210317C1 true BRPI0210317C1 (pt) | 2021-05-25 |
Family
ID=8864170
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| BRPI0210317A BRPI0210317C1 (pt) | 2001-06-11 | 2002-05-30 | complexo de vacina terapêutica destinado à prevenção ou ao tratamento de leishmanioses e infecções mediadas por microorganismos patogênicos intracelulares nos mamíferos |
Country Status (10)
| Country | Link |
|---|---|
| US (1) | US20060073170A1 (pt) |
| EP (1) | EP1395282B1 (pt) |
| AT (1) | ATE321568T1 (pt) |
| BR (1) | BRPI0210317C1 (pt) |
| CY (1) | CY1105309T1 (pt) |
| DE (1) | DE60210276T2 (pt) |
| ES (1) | ES2260440T3 (pt) |
| FR (1) | FR2825633B1 (pt) |
| PT (1) | PT1395282E (pt) |
| WO (1) | WO2002100430A1 (pt) |
Families Citing this family (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US8968749B2 (en) * | 2006-07-21 | 2015-03-03 | Universidade Federal De Minas Gerais—Ufmg | Vaccine composition and immunization method |
| ES2741730T3 (es) | 2008-05-19 | 2020-02-12 | Advaxis Inc | Sistema de administración doble para antígenos heterólogos que comprende una cepa de Listeria recombinante atenuada por la mutación de dal/dat y la deleción de ActA que comprende una molécula de ácido nucleico que codifica una proteína de fusión de listeriolisina O - antígeno prostático específico |
| US9017660B2 (en) | 2009-11-11 | 2015-04-28 | Advaxis, Inc. | Compositions and methods for prevention of escape mutation in the treatment of Her2/neu over-expressing tumors |
| US9650639B2 (en) | 2008-05-19 | 2017-05-16 | Advaxis, Inc. | Dual delivery system for heterologous antigens |
| US10016617B2 (en) | 2009-11-11 | 2018-07-10 | The Trustees Of The University Of Pennsylvania | Combination immuno therapy and radiotherapy for the treatment of Her-2-positive cancers |
| ES2595207T3 (es) * | 2010-05-07 | 2016-12-28 | Virbac | Composición de vacuna para prevenir o tratar la leishmaniosis |
| EP2621527A4 (en) | 2010-10-01 | 2015-12-09 | Univ Pennsylvania | USE OF LISTERIA VACCINE VECTORS TO REVERSE VACCINE IMMUNITY IN PATIENTS WITH PARASITIC INFECTIONS |
| EP2683400A4 (en) | 2011-03-11 | 2014-09-17 | Advaxis | ADJUVANZIA ON LISTERIA BASE |
| SG10201700392UA (en) | 2012-03-12 | 2017-03-30 | Advaxis Inc | Suppressor cell function inhibition following listeria vaccine treatment |
Family Cites Families (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4206252A (en) * | 1977-04-04 | 1980-06-03 | Gordon Roy G | Deposition method for coating glass and the like |
| US5599387A (en) * | 1993-02-16 | 1997-02-04 | Ppg Industries, Inc. | Compounds and compositions for coating glass with silicon oxide |
| FR2705358B1 (fr) * | 1993-05-13 | 1995-08-04 | Orstom | Procédé de culture in vitro de différents stades de parasites tissulaires, stades parasitaires obtenus et applications biologiques. |
| WO2000015572A2 (en) * | 1998-09-17 | 2000-03-23 | Libbey-Owens-Ford Co. | Heat strengthened coated glass article and method for making same |
| US6342925B1 (en) * | 1999-01-15 | 2002-01-29 | Sharp Laboratories Of America, Inc. | Automatic audio and video parameter adjustment |
| US7738550B2 (en) * | 2000-03-13 | 2010-06-15 | Sony Corporation | Method and apparatus for generating compact transcoding hints metadata |
| WO2002027472A1 (en) * | 2000-09-27 | 2002-04-04 | Thomson Licensing S.A. | Architecture for optimizing audio and video output states for multimedia devices |
| US6967588B2 (en) * | 2002-03-25 | 2005-11-22 | Sony Corporation | System and method for controlling a home entertainment system |
-
2001
- 2001-06-11 FR FR0107606A patent/FR2825633B1/fr not_active Expired - Fee Related
-
2002
- 2002-05-30 WO PCT/FR2002/001823 patent/WO2002100430A1/fr not_active Application Discontinuation
- 2002-05-30 AT AT02738290T patent/ATE321568T1/de not_active IP Right Cessation
- 2002-05-30 EP EP02738290A patent/EP1395282B1/fr not_active Expired - Lifetime
- 2002-05-30 PT PT02738290T patent/PT1395282E/pt unknown
- 2002-05-30 DE DE60210276T patent/DE60210276T2/de not_active Expired - Fee Related
- 2002-05-30 ES ES02738290T patent/ES2260440T3/es not_active Expired - Lifetime
- 2002-05-30 BR BRPI0210317A patent/BRPI0210317C1/pt not_active IP Right Cessation
- 2002-05-30 US US10/480,026 patent/US20060073170A1/en not_active Abandoned
-
2006
- 2006-06-19 CY CY20061100820T patent/CY1105309T1/el unknown
Also Published As
| Publication number | Publication date |
|---|---|
| DE60210276D1 (de) | 2006-05-18 |
| WO2002100430B1 (fr) | 2003-02-13 |
| ATE321568T1 (de) | 2006-04-15 |
| ES2260440T3 (es) | 2006-11-01 |
| CY1105309T1 (el) | 2010-03-03 |
| PT1395282E (pt) | 2006-07-31 |
| FR2825633A1 (fr) | 2002-12-13 |
| DE60210276T2 (de) | 2006-11-30 |
| WO2002100430A1 (fr) | 2002-12-19 |
| US20060073170A1 (en) | 2006-04-06 |
| EP1395282B1 (fr) | 2006-03-29 |
| BRPI0210317B8 (pt) | 2018-10-09 |
| FR2825633B1 (fr) | 2005-12-16 |
| BRPI0210317B1 (pt) | 2018-09-11 |
| EP1395282A1 (fr) | 2004-03-10 |
| BR0210317A (pt) | 2004-08-10 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| HRP20020593B1 (en) | Brain, spinal and nerve injury treatment | |
| GB0108592D0 (en) | Therapeutic agents | |
| BRPI0415397A (pt) | métodos e reagentes para o tratamento de desordens imunoinflamatórias | |
| WO2001045679A3 (de) | Verwendung von chemotherapeutika zur topischen behandlung | |
| BR0213100A (pt) | Combinações para o tratamento de distúrbios imuniinflamatórios | |
| BR9913225A (pt) | Novos agentes antibacterianos de isoxazolinona | |
| BR0209812A (pt) | Uso de osteopontina para o tratamento e/ou a prevenção de doenças neurológicas | |
| BR0111892A (pt) | Bis-arilsulfonas | |
| ATE319439T1 (de) | Mittel zur behandlung von erkrankungen des tracheo-bronchialtraktes, insbesondere der copd | |
| BRPI0210317C1 (pt) | complexo de vacina terapêutica destinado à prevenção ou ao tratamento de leishmanioses e infecções mediadas por microorganismos patogênicos intracelulares nos mamíferos | |
| AU6896801A (en) | Use of vegf and homologues to treat neuron disorders | |
| ATE258057T1 (de) | Therapeutische und diagnostische agenzien zur behandlung mikrobieller infektionen | |
| RS8504A (en) | Novel cyclohexil sulphones | |
| BR0211830A (pt) | Dose única de azitromicina | |
| MXPA02012857A (es) | Uso de una formulacion elaborada de o que contiene al menos un suero de leche dismilado. | |
| ATE236592T1 (de) | Aufblasbare decke mit eingeformten öffnungen | |
| BR0210632A (pt) | Tratamento de doença parasìtica | |
| HUP0003845A2 (hu) | Antimikrobiális 8a-azalidok alkalmazása | |
| BR0309684A (pt) | O tratamento de dor com ifendropil | |
| GB2377638A (en) | Treatment of infection in animals | |
| ATE341323T1 (de) | Verwendung von darifenacin zur behandlung des harndrangs | |
| DK1235573T3 (da) | Kombination af riluzol og gabapentin og anvendelse deraf som medikament ved behandling af motorneuronsygdomme | |
| BRPI0411731A (pt) | tratamento de enxaqueca acompanhada por náusea | |
| ES2166912T3 (es) | Composiciones, que comprenden bismuto y uno o mas agentes antimicrobianos, para el tratamiento y prevencion de trastornos gastrointestinales. | |
| PT1282414E (pt) | Compostos derivados de felbamato para o tratamento da dor neuropatica |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| B06F | Objections, documents and/or translations needed after an examination request according [chapter 6.6 patent gazette] | ||
| B07D | Technical examination (opinion) related to article 229 of industrial property law [chapter 7.4 patent gazette] | ||
| B07E | Notification of approval relating to section 229 industrial property law [chapter 7.5 patent gazette] | ||
| B07A | Application suspended after technical examination (opinion) [chapter 7.1 patent gazette] | ||
| B09A | Decision: intention to grant [chapter 9.1 patent gazette] | ||
| B16A | Patent or certificate of addition of invention granted [chapter 16.1 patent gazette] |
Free format text: PRAZO DE VALIDADE: 10 (DEZ) ANOS CONTADOS A PARTIR DE 11/09/2018, OBSERVADAS AS CONDICOES LEGAIS. |
|
| B16C | Correction of notification of the grant [chapter 16.3 patent gazette] |
Free format text: PRAZO DE VALIDADE: 10 (DEZ) ANOS CONTADOS A PARTIR DE 11/09/2018, OBSERVADAS AS CONDICOES LEGAIS. (CO) REFERENTE A RPI 2488 DE 11/09/2018, QUANTO AO NOME DO TITULAR. |
|
| B16C | Correction of notification of the grant [chapter 16.3 patent gazette] |
Free format text: PRAZO DE VALIDADE: 20 (VINTE) ANOS CONTADOS A PARTIR DE 30/05/2002 OBSERVADAS AS CONDICOES LEGAIS. PATENTE CONCEDIDA CONFORME ADI 5.529/DF |
|
| B21F | Lapse acc. art. 78, item iv - on non-payment of the annual fees in time |
Free format text: REFERENTE A 21A ANUIDADE. |
|
| B21H | Decision of lapse of a patent or of a certificate of addition of invention cancelled [chapter 21.8 patent gazette] |
Free format text: ANULADA A PUBLICACAO CODIGO 21.6 NA RPI NO 2725 DE 28/03/2023 POR TER SIDO INDEVIDA, UMA VEZ QUE O PRAZO DE VALIDADE DA PATENTE TERMINOU EM 30/05/2022. |
|
| B21A | Patent or certificate of addition expired [chapter 21.1 patent gazette] |
Free format text: PATENTE EXTINTA EM 30/05/2022 |